Christian A Schaer1,2, Jeremy W Deuel1, Daniela Schildknecht1, Leila Mahmoudi1, Ines Garcia-Rubio3,4, Catherine Owczarek5, Stefan Schauer6, Reinhard Kissner7, Uddyalok Banerjee8, Andre F Palmer8, Donat R Spahn2, David C Irwin9, Florence Vallelian1, Paul W Buehler9,10, Dominik J Schaer1,11. 1. 1 Division of Internal Medicine. 2. 2 Institute of Anesthesiology. 3. 3 Laboratory of Physical Chemistry and. 4. 4 Centro Universitario de la Defensa, Carretera de Huesca, Zaragoza, Spain. 5. 5 CSL Limited, Bio21 Institute, Parkville, Australia. 6. 6 Functional Genomics Center Zurich, and. 7. 7 Institute of Inorganic Chemistry, ETH Zurich, Zurich, Switzerland. 8. 8 William G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio. 9. 9 School of Medicine, University of Colorado Denver, Aurora, Colorado; and. 10. 10 Center of Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland. 11. 11 Institute of Evolutionary Medicine, University of Zurich, Zurich, Switzerland.
Abstract
RATIONALE: Hemolysis occurs not only in conditions such as sickle cell disease and malaria but also during transfusion of stored blood, extracorporeal circulation, and sepsis. Cell-free Hb depletes nitric oxide (NO) in the vasculature, causing vasoconstriction and eventually cardiovascular complications. We hypothesize that Hb-binding proteins may preserve vascular NO signaling during hemolysis. OBJECTIVES: Characterization of an archetypical function by which Hb scavenger proteins could preserve NO signaling during hemolysis. METHODS: We investigated NO reaction kinetics, effects on arterial NO signaling, and tissue distribution of cell-free Hb and its scavenger protein complexes. MEASUREMENTS AND MAIN RESULTS: Extravascular translocation of cell-free Hb into interstitial spaces, including the vascular smooth muscle cell layer of rat and pig coronary arteries, promotes vascular NO resistance. This critical disease process is blocked by haptoglobin. Haptoglobin does not change NO dioxygenation rates of Hb; rather, the large size of the Hb:haptoglobin complex prevents Hb extravasation, which uncouples NO/Hb interaction and vasoconstriction. Size-selective compartmentalization of Hb functions as a substitute for red blood cells after hemolysis and preserves NO signaling in the vasculature. We found that evolutionarily and structurally unrelated Hb-binding proteins, such as PIT54 found in avian species, functionally converged with haptoglobin to protect NO signaling by sequestering cell-free Hb in large protein complexes. CONCLUSIONS: Sequential compartmentalization of Hb by erythrocytes and scavenger protein complexes is an archetypical mechanism, which may have supported coevolution of hemolysis and normal vascular function. Therapeutic supplementation of Hb scavengers may restore vascular NO signaling and attenuate disease complications in patients with hemolysis.
RATIONALE: Hemolysis occurs not only in conditions such as sickle cell disease and malaria but also during transfusion of stored blood, extracorporeal circulation, and sepsis. Cell-free Hb depletes nitric oxide (NO) in the vasculature, causing vasoconstriction and eventually cardiovascular complications. We hypothesize that Hb-binding proteins may preserve vascular NO signaling during hemolysis. OBJECTIVES: Characterization of an archetypical function by which Hb scavenger proteins could preserve NO signaling during hemolysis. METHODS: We investigated NO reaction kinetics, effects on arterial NO signaling, and tissue distribution of cell-free Hb and its scavenger protein complexes. MEASUREMENTS AND MAIN RESULTS: Extravascular translocation of cell-free Hb into interstitial spaces, including the vascular smooth muscle cell layer of rat and pig coronary arteries, promotes vascular NO resistance. This critical disease process is blocked by haptoglobin. Haptoglobin does not change NO dioxygenation rates of Hb; rather, the large size of the Hb:haptoglobin complex prevents Hb extravasation, which uncouples NO/Hb interaction and vasoconstriction. Size-selective compartmentalization of Hb functions as a substitute for red blood cells after hemolysis and preserves NO signaling in the vasculature. We found that evolutionarily and structurally unrelated Hb-binding proteins, such as PIT54 found in avian species, functionally converged with haptoglobin to protect NO signaling by sequestering cell-free Hb in large protein complexes. CONCLUSIONS: Sequential compartmentalization of Hb by erythrocytes and scavenger protein complexes is an archetypical mechanism, which may have supported coevolution of hemolysis and normal vascular function. Therapeutic supplementation of Hb scavengers may restore vascular NO signaling and attenuate disease complications in patients with hemolysis.
Authors: Irene Gramaglia; Peter Sobolewski; Diana Meays; Ramiro Contreras; John P Nolan; John A Frangos; Marcos Intaglietta; Henri C van der Heyde Journal: Nat Med Date: 2006-11-12 Impact factor: 53.440
Authors: Chenell Donadee; Nicolaas J H Raat; Tamir Kanias; Jesús Tejero; Janet S Lee; Eric E Kelley; Xuejun Zhao; Chen Liu; Hannah Reynolds; Ivan Azarov; Sheila Frizzell; E Michael Meyer; Albert D Donnenberg; Lirong Qu; Darrel Triulzi; Daniel B Kim-Shapiro; Mark T Gladwin Journal: Circulation Date: 2011-07-11 Impact factor: 29.690
Authors: Jon A Detterich; Roberta M Kato; Miklos Rabai; Herbert J Meiselman; Thomas D Coates; John C Wood Journal: Blood Date: 2015-06-02 Impact factor: 22.113
Authors: Chris E Cooper; Dominik J Schaer; Paul W Buehler; Michael T Wilson; Brandon J Reeder; Gary Silkstone; Dimitri A Svistunenko; Leif Bulow; Abdu I Alayash Journal: Antioxid Redox Signal Date: 2012-08-06 Impact factor: 8.401
Authors: Christopher D Reiter; Xunde Wang; Jose E Tanus-Santos; Neil Hogg; Richard O Cannon; Alan N Schechter; Mark T Gladwin Journal: Nat Med Date: 2002-11-11 Impact factor: 53.440
Authors: Binglan Yu; Michael J Raher; Gian Paolo Volpato; Kenneth D Bloch; Fumito Ichinose; Warren M Zapol Journal: Circulation Date: 2008-04-07 Impact factor: 29.690
Authors: Olga Rafikova; Elissa R Williams; Matthew L McBride; Marina Zemskova; Anup Srivastava; Vineet Nair; Ankit A Desai; Paul R Langlais; Evgeny Zemskov; Marc Simon; Lawrence J Mandarino; Ruslan Rafikov Journal: Am J Respir Cell Mol Biol Date: 2018-09 Impact factor: 6.914
Authors: Jan A Graw; Binglan Yu; Emanuele Rezoagli; H Shaw Warren; Emmanuel S Buys; Donald B Bloch; Warren M Zapol Journal: Am J Physiol Heart Circ Physiol Date: 2017-03-17 Impact factor: 4.733
Authors: Michael Hugelshofer; Raphael M Buzzi; Christian A Schaer; Henning Richter; Kevin Akeret; Vania Anagnostakou; Leila Mahmoudi; Raphael Vaccani; Florence Vallelian; Jeremy W Deuel; Peter W Kronen; Zsolt Kulcsar; Luca Regli; Jin Hyen Baek; Ivan S Pires; Andre F Palmer; Matthias Dennler; Rok Humar; Paul W Buehler; Patrick R Kircher; Emanuela Keller; Dominik J Schaer Journal: J Clin Invest Date: 2019-12-02 Impact factor: 14.808
Authors: Ryan Hunt; Ayla Yalamanoglu; James Tumlin; Tal Schiller; Jin Hyen Baek; Andrew Wu; Agnes B Fogo; Haichun Yang; Edward Wong; Peter Miller; Paul W Buehler; Chava Kimchi-Sarfaty Journal: Blood Date: 2016-11-18 Impact factor: 22.113
Authors: Patricia A Shi; Erika Choi; Narendranath R Chintagari; Julia Nguyen; Xinhua Guo; Karina Yazdanbakhsh; Narla Mohandas; Abdu I Alayash; Elizabeth A Manci; John D Belcher; Gregory M Vercellotti Journal: Br J Haematol Date: 2016-08-10 Impact factor: 6.998